| 摘要 |
<p>Two diagnostic methods for evaluating LDL metabolism in a patient are disclosed. A novel diagnostic agent for evaluating LDL metabolism comprising a ligand capable of binding LDL receptors and a fluorescent label and a diagnostic kit for evaluating LDL metabolism which utilized the specified diagnostic agent are also disclosed.</p> |
